# Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD

> **NCT03446885** · PHASE4 · COMPLETED · sponsor: **Gregory Fabiano** · enrollment: 22 (actual)

## Conditions studied

- Attention Deficit Disorder With Hyperactivity

## Interventions

- **DRUG:** Lisdexamfetamine Dimesylate 40 MG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03446885
- **Lead sponsor:** Gregory Fabiano
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-01
- **Primary completion:** 2019-02-11
- **Final completion:** 2019-08-30
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2021-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03446885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03446885, "Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03446885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*